首页 > 最新文献

Aktuelle Urologie最新文献

英文 中文
[Ex-vivo Comparative Study on the Morcellation Efficiency of Different Morcellators]. [不同粉碎器粉碎效率的离体比较研究]。
IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-09-01 Epub Date: 2025-04-23 DOI: 10.1055/a-2560-3827
Benedikt Becker, Christopher Netsch, Andreas J Gross, Clemens Rosenbaum, Friedrich Otto Hartung, Simon Filmar, Sophia Hook

Anatomical enucleation of the prostate (AEEP) is an established treatment option for benign prostatic hyperplasia (BPH), regardless of prostate size. While advancements in laser technology have significantly improved the enucleation phase, the morcellation process has remained relatively unchanged, with limited innovations in morcellation devices. This study aimed to compare the efficiency of two morcellators in an ex-vivo model: the Piranha morcellator (Richard Wolf GmbH, Knittlingen) and a newly introduced, yet-to-be-commercialized device, the ActiveCut morcellator (Active Fiber Systems GmbH, Jena).The two morcellators were tested in a newly developed ex-vivo model. In both groups, reusable blades were tested ten times at comparable speed settings. For each trial, 60 grams of raw bovine heart tissue were morcellated. The efficiency of the morcellation was then analyzed. Primary endpoints included morcellation efficiency (g/min) and an evaluation of blade deterioration over repeated use. The mean values of continuous variables were compared using a t-test with standard deviation.A total of ten consecutive morcellation trials were conducted with each device. The ActiveCut demonstrated higher morcellation rates at 12.43 g/min, compared to 7.09 g/min with the Piranha morcellator (p<0.05). However, the ActiveCut showed a decline in efficiency over ten trials. In two cases, tissue had to be manually removed from the blade coupling during morcellation, whereas the Piranha morcellator maintained consistent performance without malfunctions.In this ex-vivo study, comparing the ActiveCut and Piranha morcellators, the ActiveCut exhibited higher morcellation efficiency. However, as the ActiveCut has not yet undergone clinical testing, future clinical studies are necessary to assess its safety and potential malfunctions before clinical implementation.

解剖性前列腺摘除(AEEP)是治疗良性前列腺增生(BPH)的常用方法,与前列腺大小无关。虽然激光技术的进步大大改善了去核阶段,但粉碎过程仍然保持相对不变,粉碎设备的创新有限。本研究的目的是在离体模型中比较两种粉碎器的效率:Piranha粉碎器(Richard Wolf GmbH, Knittlingen)和一种新推出的尚未商业化的设备ActiveCut粉碎器(Active Fiber Systems GmbH, Jena)。这两种粉碎剂在新开发的离体模型中进行了测试。在两组中,可重复使用的叶片在相同的速度设置下测试了10次。在每次试验中,将60克生牛心脏组织粉碎。并对粉碎效率进行了分析。主要终点包括粉碎效率(g/min)和反复使用后叶片退化的评估。连续变量的均值比较采用带标准差的t检验。每台设备共进行了10次连续粉碎试验。ActiveCut的粉碎速率为12.43 g/min,而Piranha粉碎机的粉碎速率为7.09 g/min
{"title":"[Ex-vivo Comparative Study on the Morcellation Efficiency of Different Morcellators].","authors":"Benedikt Becker, Christopher Netsch, Andreas J Gross, Clemens Rosenbaum, Friedrich Otto Hartung, Simon Filmar, Sophia Hook","doi":"10.1055/a-2560-3827","DOIUrl":"10.1055/a-2560-3827","url":null,"abstract":"<p><p>Anatomical enucleation of the prostate (AEEP) is an established treatment option for benign prostatic hyperplasia (BPH), regardless of prostate size. While advancements in laser technology have significantly improved the enucleation phase, the morcellation process has remained relatively unchanged, with limited innovations in morcellation devices. This study aimed to compare the efficiency of two morcellators in an ex-vivo model: the Piranha morcellator (Richard Wolf GmbH, Knittlingen) and a newly introduced, yet-to-be-commercialized device, the ActiveCut morcellator (Active Fiber Systems GmbH, Jena).The two morcellators were tested in a newly developed ex-vivo model. In both groups, reusable blades were tested ten times at comparable speed settings. For each trial, 60 grams of raw bovine heart tissue were morcellated. The efficiency of the morcellation was then analyzed. Primary endpoints included morcellation efficiency (g/min) and an evaluation of blade deterioration over repeated use. The mean values of continuous variables were compared using a t-test with standard deviation.A total of ten consecutive morcellation trials were conducted with each device. The ActiveCut demonstrated higher morcellation rates at 12.43 g/min, compared to 7.09 g/min with the Piranha morcellator (p<0.05). However, the ActiveCut showed a decline in efficiency over ten trials. In two cases, tissue had to be manually removed from the blade coupling during morcellation, whereas the Piranha morcellator maintained consistent performance without malfunctions.In this ex-vivo study, comparing the ActiveCut and Piranha morcellators, the ActiveCut exhibited higher morcellation efficiency. However, as the ActiveCut has not yet undergone clinical testing, future clinical studies are necessary to assess its safety and potential malfunctions before clinical implementation.</p>","PeriodicalId":7513,"journal":{"name":"Aktuelle Urologie","volume":" ","pages":"433-438"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143953540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Bladder neck contracture after surgery for benigne prostate hyperplasia]. [良性前列腺增生术后膀胱颈挛缩]。
IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-09-01 Epub Date: 2025-07-09 DOI: 10.1055/a-2645-6997
Clemens Rosenbaum, Sophia Hook, Benedikt Becker, Christopher Netsch, Simon Filmar

Bladder neck contracture (BNC) is a common complication following surgical treatment of benign prostatic hyperplasia (BPH), with incidence rates varying depending on the therapeutic approach. Numerous techniques for managing BNC have been described in the literature. For the initial presentation of BNC, endoscopic treatment is generally recommended as the first-line therapy. In cases of recurrent BNC, however, open surgical reconstruction, such as YV or T-plasty, is considered the preferred treatment option. Additionally, robot-assisted surgery is increasingly being integrated into the surgical management of BNC. Currently, no standardized treatment protocol exists for this condition. This review provides a systematic overview of bladder neck contracture and the current therapeutic strategies available.

膀胱颈挛缩(BNC)是手术治疗良性前列腺增生(BPH)后常见的并发症,其发病率因治疗方法而异。文献中描述了许多管理BNC的技术。对于BNC的初始表现,内镜治疗通常被推荐为一线治疗。然而,对于复发性BNC,开放手术重建,如YV或t形成形术,被认为是首选的治疗选择。此外,机器人辅助手术越来越多地融入到BNC的手术管理中。目前,没有针对这种情况的标准化治疗方案。这篇综述提供了膀胱颈挛缩的系统概述和目前可用的治疗策略。
{"title":"[Bladder neck contracture after surgery for benigne prostate hyperplasia].","authors":"Clemens Rosenbaum, Sophia Hook, Benedikt Becker, Christopher Netsch, Simon Filmar","doi":"10.1055/a-2645-6997","DOIUrl":"10.1055/a-2645-6997","url":null,"abstract":"<p><p>Bladder neck contracture (BNC) is a common complication following surgical treatment of benign prostatic hyperplasia (BPH), with incidence rates varying depending on the therapeutic approach. Numerous techniques for managing BNC have been described in the literature. For the initial presentation of BNC, endoscopic treatment is generally recommended as the first-line therapy. In cases of recurrent BNC, however, open surgical reconstruction, such as YV or T-plasty, is considered the preferred treatment option. Additionally, robot-assisted surgery is increasingly being integrated into the surgical management of BNC. Currently, no standardized treatment protocol exists for this condition. This review provides a systematic overview of bladder neck contracture and the current therapeutic strategies available.</p>","PeriodicalId":7513,"journal":{"name":"Aktuelle Urologie","volume":" ","pages":"451-455"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144599094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benigne Prostatahyperplasie.
IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-09-01 Epub Date: 2025-08-26 DOI: 10.1055/a-2517-3489
Benedikt Becker
{"title":"Benigne Prostatahyperplasie.","authors":"Benedikt Becker","doi":"10.1055/a-2517-3489","DOIUrl":"https://doi.org/10.1055/a-2517-3489","url":null,"abstract":"","PeriodicalId":7513,"journal":{"name":"Aktuelle Urologie","volume":"56 5","pages":"388-389"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144938952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kommentar zum Leserbrief. 读者评论。
IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-09-01 Epub Date: 2025-08-26 DOI: 10.1055/a-2639-7539
{"title":"Kommentar zum Leserbrief.","authors":"","doi":"10.1055/a-2639-7539","DOIUrl":"https://doi.org/10.1055/a-2639-7539","url":null,"abstract":"","PeriodicalId":7513,"journal":{"name":"Aktuelle Urologie","volume":"56 5","pages":"430-431"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144938940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kommentar. .评论
IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-09-01 Epub Date: 2025-08-26 DOI: 10.1055/a-2604-8426
{"title":"Kommentar.","authors":"","doi":"10.1055/a-2604-8426","DOIUrl":"https://doi.org/10.1055/a-2604-8426","url":null,"abstract":"","PeriodicalId":7513,"journal":{"name":"Aktuelle Urologie","volume":"56 5","pages":"406-407"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144938978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Randomised comparison of different exit strategies in hydrocele resection]. [鞘膜积液切除术中不同退出策略的随机比较]。
IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-09-01 Epub Date: 2023-11-14 DOI: 10.1055/a-2159-1525
Simon Filmar, Andreas Gross, Christopher Netsch, Clemens Rosenbaum, Benedikt Becker

Introduction: Adult hydrocele is a benign enlargement of the scrotum seen in approximately 60/100,000 men >18 years of age. Surgical resection of the hydrocele has been established as the gold standard for the treatment of symptomatic hydroceles. Postoperative complications are common with this surgery. Due to the lack of guidelines for the therapy of hydrocele, treatment is based primarily on clinical experience. The aim of the study was to conduct a randomised study on the influence of drains on complications in hydrocele resection according to von Bergmann.

Material and methods: A total of 60 patients were prospectively randomised into three groups. The groups each received an Easy-Flow drainage, a Cuti-Med Sorbact drainage, or no drainage. Haematoma and swelling, postoperative bleeding, infection, epididymal injury and revision surgery were clinically diagnosed as complications.

Results: A complication was observed in 31.6% (n=19/60) of all patients. The complication rate was 50% (n=10) for the easy-flow drainage, 30% (n=6) for the Cuti-Med-Sorbact and 15% (n=3) for the group without drainage. Overall, a haematoma with swelling was observed most frequently, in 20% (n=12) of the cases. Revision surgery was required in 5% (n=3) of cases. Epididymal injuries were found histologically in 10% (n=6). Comparing the collective with the Easy-Flow drainage with the collective without drainage, the occurrence of complications was observed significantly more frequently in the drainage group (p<0.018). A statistically significant correlation regarding complications between the group of Cuti-Med-Sorbact and no drainage could not be shown (p<0.25).

Conclusions: Hydrocele resection is a complicated procedure. Based on the data presented here, the insertion of a drain is associated with an increased risk of postoperative complications. If the decision to insert a wound drainage is made intraoperatively, the Cuti-Med-Sorbact drainage appears to be associated with fewer complications.

成人鞘膜积液是一种良性的阴囊肿大,在18岁以下的男性中约有60/10万。手术切除鞘膜积液已被确立为治疗症状性鞘膜积液的金标准。这种手术的术后并发症很常见。由于缺乏治疗鞘膜积液的指南,治疗主要基于临床经验。根据von Bergmann的说法,本研究的目的是对引流管对鞘膜积液切除术并发症的影响进行随机研究。材料与方法:60例患者前瞻性随机分为三组。各组均采用Easy-Flow引流、Cuti-Med Sorbact引流或不引流。血肿肿胀、术后出血、感染、附睾损伤及翻修手术临床诊断为并发症。结果:31.6% (n=19/60)的患者出现并发症。易流引流组并发症发生率为50% (n=10), Cuti-Med-Sorbact组为30% (n=6),不引流组为15% (n=3)。总体而言,血肿伴肿胀最为常见,占20% (n=12)的病例。5% (n=3)的病例需要进行翻修手术。组织学上发现附睾损伤10% (n=6)。结论:鞘膜积液切除术是一项复杂的手术,其并发症的发生率明显高于引流组、易流引流组和不引流组。根据本文提供的数据,插入引流管与术后并发症的风险增加有关。如果术中决定置入伤口引流管,那么Cuti-Med-Sorbact引流管的并发症似乎较少。
{"title":"[Randomised comparison of different exit strategies in hydrocele resection].","authors":"Simon Filmar, Andreas Gross, Christopher Netsch, Clemens Rosenbaum, Benedikt Becker","doi":"10.1055/a-2159-1525","DOIUrl":"10.1055/a-2159-1525","url":null,"abstract":"<p><strong>Introduction: </strong>Adult hydrocele is a benign enlargement of the scrotum seen in approximately 60/100,000 men >18 years of age. Surgical resection of the hydrocele has been established as the gold standard for the treatment of symptomatic hydroceles. Postoperative complications are common with this surgery. Due to the lack of guidelines for the therapy of hydrocele, treatment is based primarily on clinical experience. The aim of the study was to conduct a randomised study on the influence of drains on complications in hydrocele resection according to von Bergmann.</p><p><strong>Material and methods: </strong>A total of 60 patients were prospectively randomised into three groups. The groups each received an Easy-Flow drainage, a Cuti-Med Sorbact drainage, or no drainage. Haematoma and swelling, postoperative bleeding, infection, epididymal injury and revision surgery were clinically diagnosed as complications.</p><p><strong>Results: </strong>A complication was observed in 31.6% (n=19/60) of all patients. The complication rate was 50% (n=10) for the easy-flow drainage, 30% (n=6) for the Cuti-Med-Sorbact and 15% (n=3) for the group without drainage. Overall, a haematoma with swelling was observed most frequently, in 20% (n=12) of the cases. Revision surgery was required in 5% (n=3) of cases. Epididymal injuries were found histologically in 10% (n=6). Comparing the collective with the Easy-Flow drainage with the collective without drainage, the occurrence of complications was observed significantly more frequently in the drainage group (p<0.018). A statistically significant correlation regarding complications between the group of Cuti-Med-Sorbact and no drainage could not be shown (p<0.25).</p><p><strong>Conclusions: </strong>Hydrocele resection is a complicated procedure. Based on the data presented here, the insertion of a drain is associated with an increased risk of postoperative complications. If the decision to insert a wound drainage is made intraoperatively, the Cuti-Med-Sorbact drainage appears to be associated with fewer complications.</p>","PeriodicalId":7513,"journal":{"name":"Aktuelle Urologie","volume":" ","pages":"477-483"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"107589972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Invasives Harnblasenkarzinom: Trimodale Therapie versus radikale Zystektomie. “三模治疗与根治性膀胱癌”。
IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-09-01 Epub Date: 2025-08-26 DOI: 10.1055/a-2549-8807
{"title":"Invasives Harnblasenkarzinom: Trimodale Therapie versus radikale Zystektomie.","authors":"","doi":"10.1055/a-2549-8807","DOIUrl":"https://doi.org/10.1055/a-2549-8807","url":null,"abstract":"","PeriodicalId":7513,"journal":{"name":"Aktuelle Urologie","volume":"56 5","pages":"407-409"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144938937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Harnröhrenstriktur: Langzeitergebnisse nach perinealer Urethrostomie. “围产期尿道造口术的长期结果”。
IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-09-01 Epub Date: 2025-08-26 DOI: 10.1055/a-2549-8853
{"title":"Harnröhrenstriktur: Langzeitergebnisse nach perinealer Urethrostomie.","authors":"","doi":"10.1055/a-2549-8853","DOIUrl":"https://doi.org/10.1055/a-2549-8853","url":null,"abstract":"","PeriodicalId":7513,"journal":{"name":"Aktuelle Urologie","volume":"56 5","pages":"414-416"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144938949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benigne Prostatahyperplasie: Prostataarterienembolisation versus transurethrale Resektion. 良性前列腺增生:前列腺动脉栓塞与经尿道切除。
IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-09-01 Epub Date: 2025-08-26 DOI: 10.1055/a-2321-2381
{"title":"Benigne Prostatahyperplasie: Prostataarterienembolisation versus transurethrale Resektion.","authors":"","doi":"10.1055/a-2321-2381","DOIUrl":"https://doi.org/10.1055/a-2321-2381","url":null,"abstract":"","PeriodicalId":7513,"journal":{"name":"Aktuelle Urologie","volume":"56 5","pages":"410-412"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144938925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Benign prostatic hyperplasia with bladder emptying disorder in geriatric patients: active (pharmacological or surgical) treatment vs. catheterization]. [老年患者良性前列腺增生伴膀胱排空障碍:积极(药物或手术)治疗vs导尿]。
IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-09-01 Epub Date: 2025-06-05 DOI: 10.1055/a-2599-8213
Peter Jochen Olbert

Epidemiological data demonstrate a clear association between age, prostatic enlargement, and the associated symptoms. Benign prostatic syndromes usually take a chronic progressive course, and a significant share of BPS patients faced with the decision "conservative vs. surgical treatment" are of advanced age and suffer from numerous comorbidities, which means that the principle of "nihil nocere" must be given special consideration. A benefit-risk assessment must be carried out very carefully both for pharmacological and surgical treatment. Having reviewed the literature, including the relevant guidelines, the author concludes that, if a relevant indication exists, there are hardly any reasons to deny geriatric patients one of the numerous interventional options, perhaps with the exception of a patient population that is already in need of long-term care.

流行病学资料显示年龄、前列腺增大和相关症状之间有明确的关联。良性前列腺综合征通常呈慢性进行性病程,在选择“保守治疗还是手术治疗”的BPS患者中,有很大一部分是高龄患者,且有许多合并症,这意味着必须特别考虑“无病灶”的原则。药理学和外科治疗都必须非常仔细地进行获益-风险评估。在回顾了包括相关指南在内的文献后,作者得出结论,如果存在相关指征,那么几乎没有任何理由拒绝老年患者的众多介入选择之一,也许除了已经需要长期护理的患者群体。
{"title":"[Benign prostatic hyperplasia with bladder emptying disorder in geriatric patients: active (pharmacological or surgical) treatment vs. catheterization].","authors":"Peter Jochen Olbert","doi":"10.1055/a-2599-8213","DOIUrl":"10.1055/a-2599-8213","url":null,"abstract":"<p><p>Epidemiological data demonstrate a clear association between age, prostatic enlargement, and the associated symptoms. Benign prostatic syndromes usually take a chronic progressive course, and a significant share of BPS patients faced with the decision \"conservative vs. surgical treatment\" are of advanced age and suffer from numerous comorbidities, which means that the principle of \"nihil nocere\" must be given special consideration. A benefit-risk assessment must be carried out very carefully both for pharmacological and surgical treatment. Having reviewed the literature, including the relevant guidelines, the author concludes that, if a relevant indication exists, there are hardly any reasons to deny geriatric patients one of the numerous interventional options, perhaps with the exception of a patient population that is already in need of long-term care.</p>","PeriodicalId":7513,"journal":{"name":"Aktuelle Urologie","volume":" ","pages":"439-444"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144232940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Aktuelle Urologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1